155 related articles for article (PubMed ID: 30030909)
1. Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders.
Jensen C; Nielsen SH; Mortensen JH; Kjeldsen J; Klinge LG; Krag A; Harling H; Jørgensen LN; Karsdal MA; Willumsen N
Cancer Med; 2018 Sep; 7(9):4619-4626. PubMed ID: 30030909
[TBL] [Abstract][Full Text] [Related]
2. A Fragment of Collagen Type VI alpha-3 chain is Elevated in Serum from Patients with Gastrointestinal Disorders.
Holm Nielsen S; Mortensen JH; Willumsen N; Rasmussen DGK; Mogensen DJ; Di Sabatino A; Mazza G; Jørgensen LN; Giuffrida P; Pinzani M; Klinge L; Kjeldsen J; Leeming DJ; Karsdal MA; Genovese F
Sci Rep; 2020 Apr; 10(1):5910. PubMed ID: 32245981
[TBL] [Abstract][Full Text] [Related]
3. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis.
Yoshizawa S; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Mukai M; Fujita T; Kawakami Y; Hibi T
Inflamm Bowel Dis; 2007 Jul; 13(7):865-73. PubMed ID: 17285596
[TBL] [Abstract][Full Text] [Related]
5. Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer.
Willumsen N; Jorgensen LN; Karsdal MA
Cancer Biol Ther; 2019; 20(5):692-699. PubMed ID: 30626261
[TBL] [Abstract][Full Text] [Related]
6. The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer.
Xia Z; Zhang G; Wang C; Feng Y
Adv Med Sci; 2021 Mar; 66(1):89-97. PubMed ID: 33461100
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
[TBL] [Abstract][Full Text] [Related]
8. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
9. Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis.
Nielsen MJ; Thorburn D; Leeming DJ; Hov JR; Nygård S; Moum B; Saffioti F; Gilja OH; Boberg KM; Mazza G; Røsjø H; Pinzani M; Karlsen TH; Karsdal MA; Vesterhus M
Aliment Pharmacol Ther; 2018 Jul; 48(2):179-189. PubMed ID: 29851098
[TBL] [Abstract][Full Text] [Related]
10. Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma.
Zdravkovic ND; Jovanovic IP; Radosavljevic GD; Arsenijevic AN; Zdravkovic ND; Mitrovic SLj; Arsenijevic NN
Int J Med Sci; 2014; 11(9):936-47. PubMed ID: 25076849
[TBL] [Abstract][Full Text] [Related]
11. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
13. SnoRNAs are involved in the progression of ulcerative colitis and colorectal cancer.
Yang X; Li Y; Li L; Liu J; Wu M; Ye M
Dig Liver Dis; 2017 May; 49(5):545-551. PubMed ID: 28110922
[TBL] [Abstract][Full Text] [Related]
14. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
17. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
[TBL] [Abstract][Full Text] [Related]
18. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis.
Kanmura S; Uto H; Numata M; Hashimoto S; Moriuchi A; Fujita H; Oketani M; Ido A; Kodama M; Ohi H; Tsubouchi H
Inflamm Bowel Dis; 2009 Jun; 15(6):909-17. PubMed ID: 19107772
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
